Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana

Authors

• Claudia Simoes-Pires aSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland
• Kurt Hostettmann aSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland
• Amina Haouala aSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland
• Muriel Cuendet aSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland
• Jacques Falquet bDepartment of Plant Biology, University of Geneva, Quai Ernest-Ansermet 30, CH-1211 Geneva 4, Switzerland
• Bertrand Graz cInstitut de médecine sociale et préventive, University of Geneva, rue Michel Servet 1, CH-1211 Genève 4, Switzerland
• Philippe Christen aSchool of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest-Ansermet 30, 1211 Geneva 4, Switzerland